- Home
- Equipment
- canada alberta
- respiratory allergy
Show results for
Refine by
Respiratory Allergy Equipment & Supplies In Alberta
5 equipment items found
Manufactured by:InvivoGen based inToulouse, FRANCE
A549-Dual cells are adherent epithelial cells that have been derived from the human A549 lung carcinoma cell line by stable integration of two inducible reporter constructs. The A549 cell line is a well-characterized cellular model for asthma, allergies and respiratory ...
Manufactured by:Economy Polymers & Chemicals based inHouston, TEXAS (USA)
A. EMERGENCY OVERVIEW: Physical Appearance and Odor: off-white powder solid, bean-like odor. Warning Statements: MAY CAUSE ALLERGIC RESPIRATORY REACTION. MAY CAUSE EYE IRRITATION. B. POTENTIAL HEALTH EFFECTS: Acute Eye: Severe irritant. Acute Skin: Skin absorption not likely. May cause redness, inflammation, severe irritant. Acute Inhalation: Some individuals may develop a respiratory allergenic ...
Manufactured by:Citeq Biologics based inGroningen, NETHERLANDS
Lepidoglyphus destructor, also known as storage mite, belongs to the Acaridae family. In Europe, Lepidoglyphus destructor has been reported to be a major source of mite allergy in rural and urban environments. Our Lepidoglyphus destructor extract and whole culture are delivered in freeze-dried form and available from ...
Manufactured by:Intrommune Therapeutics based inNew York, NEW YORK (USA)
Intrommune has developed a novel drug delivery platform—oral mucosal immunotherapy (OMIT)—for the treatment of food allergies. Therapeutic agents are embedding in fully functioning toothpaste so that treatment can be conveniently administered during a patient’s daily toothbrushing ...
Manufactured by:Lupagen Inc. based inDallas, TEXAS (USA)
Lupagen avoids the cost & complexity of cell therapy and the safety & clinical challenges of viral-based gene therapy by a simple patient-connected gene delivery procedure done at the bedside. Our Side CAR-T® delivery system, a first-in-class bedside system enables gene delivery directly to target cells in a highly-controlled and safe environment before reinfusing therapies to the ...